Low-dose versus High-dose Carfilzomib with Dexamethasone (S1304) in Patients with Relapsed-Refractory Multiple Myeloma. [electronic resource]
Producer: 20211101Description: 3969-3978 p. digitalISSN:- 1557-3265
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Cross-Over Studies
- Dexamethasone -- administration & dosage
- Drug Administration Schedule
- Drug Resistance, Neoplasm
- Female
- Follow-Up Studies
- Humans
- Infusions, Intravenous
- Male
- Middle Aged
- Multiple Myeloma -- drug therapy
- Neoplasm Recurrence, Local -- drug therapy
- Oligopeptides -- administration & dosage
- Progression-Free Survival
No physical items for this record
Publication Type: Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.